Skip to main content
Clinical Trials/NCT01446315
NCT01446315UnknownPhase 4

Assessing Decision Maker Tools for Asthma: the Asthma APGAR

Olmsted Medical Center1 site in 1 country1,500 target enrollmentStarted: October 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Enrollment
1,500
Locations
1
Primary Endpoint
Asthma Quality of Life Questionnaire (AQLQ)

Study Overview

Brief Summary

Asthma is a common problem among US adults and children. Unfortunately many people with asthma continue to suffer from asthma symptoms that could be control with better asthma care and more attention to details such as triggers, and adherence. To date the only tools available and recommended by groups such as the national asthma guideline group consider only asthma burden and do not include information on the most common factors that adversely affect asthma control. This study provides one half of the enrolled primary care offices with the Asthma APGAR which is a system of patient completed questions and a care flow sheet. The other half of the enrolled practices will continue to provide "usual" care without the support of the Asthma APGAR system. The research questions is whether or not asthma control and asthma related quality of life will be improved in people with asthma who are cared for in the intervention practices that use the Asthma APGAR system.

Detailed Description

Since this is a practice intervention study, the practices are randomized and all patients enrolled within each practice receive either the intervention based care or the usual care.

The primary outcome is asthma related quality of life obtained from patient report. Other outcomes include asthma control, also a patient reported outcome, and number of exacerbations which is obtained from patient medical record review.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
5 Years to 60 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Have physician diagnosed asthma
  • •Male or female between ages 5 through 60 years
  • •Have persistent asthma as assessed by daily use of "controller" medication
  • •Receive continuity care at practice where enrolled.
  • •Not have been in ICU for asthma ever
  • •Do not require daily or every other day oral steroids for asthma control

Exclusion Criteria

  • •Cannot read and speak English
  • •Child refuses assent

Arms & Interventions

Asthma APGAR

Experimental

Use of new asthma care tools. Primary care practices will be provided and educated about the Asthma APGAR tool system to guide asthma care. The practices will adopt this system for all people in their practices with asthma. Outcomes will be assessed only for those who meet enrollment criteria and sign informed consent.

Intervention: Use of Asthma APGAR system and tools (Behavioral)

Usual care

Placebo Comparator

Usual asthma care as provided by the sites.

Intervention: Asthma APGAR tools (Behavioral)

Outcomes

Primary Outcomes

Asthma Quality of Life Questionnaire (AQLQ)

Time Frame: 12 months

Chagne in asthma relted quality of life from basline (enrollment date) to 12 months later

Secondary Outcomes

  • Exacerbation rate(12 months)
  • Asthma Control Questionnaire(12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Barbara P. Yawn, MD, MSc

Director of Research

Olmsted Medical Center

Study Sites (1)

Loading locations...

Similar Trials